Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - April 2014


7th Annual Proteins & Antibodies Congress

03 Apr 2014 - 04 Apr 2014 - London, UK



Bookmark and Share


Over 400 attendees working within Proteins, Antibodies and Biotherapeutics

Over 40 case studies, presentations and panel discussions

Co-Located with our Biosimilars & Biobetters Congress and Peptides Congress

4 interactive streams:

  • Antibody Discovery & Development
  • Protein Purification, Expression & Characterisation
  • Antibody Engineering
  • Biotherapeutics Optimisation

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities

Oxford Global Conferences are proud to present the 7th Annual Proteins & Antibodies Congress, taking place on 3rd & 4th April 2014 at the Novotel London West, UK.

Over two days, this meeting will bring together over 400 senior-level decision makers working at the forefront of the proteins and antibodies field in Europe and the US. The conference programme consists of world-class keynote addresses, industry and academic led presentations and panel debates, creating an interactive platform for high-level scientific and business discussion.

Our panel of Antibody experts will discuss the latest antibody discovery targets and development platforms. Day Two will feature case studies on increasing clinical success rate and the latest insights into armed antibodies and antibody-cytokine fusions.

The Protein Purification, Expression & Characterisation stream will explore the critical issues in protein crystallisation, assays, protein folding and cell line selection.

The Biotherapeutics Optimisation stream will explore the areas of alternative scaffolds and targeted delivery. Our internationally renowned speakers will discuss overcoming the challenges of immunogenicity and aggregation and debate the future of biopharmaceutical development.



Further information
Scientific News
Food Triggers Creation of Regulatory T Cells
IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Cellular 'Relief Valve'
A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.
Switch Lets Salmonella Fight, Evade Immune System
Researchers at the University of Illinois at Chicago have discovered a molecular regulator that allows salmonella bacteria to switch from actively causing disease to lurking in a chronic but asymptomatic state called a biofilm.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Neural Networks Adapt to the Presence of a Toxic HIV Protein
HIV-associated neurocognitive disorders (HAND) afflict approximately half of HIV infected patients.
HIV Protein Manipulates Hundreds of Human Genes
Findings search for new or improved treatments for patients with AIDS.
Breaking the Brain’s Garbage Disposal
The children’s ataxia gene problem turned out to be not such a big deal genetically — it was such a slight mutation that it barely changed the way the cells made the protein.
Flesh-Eating Bacteria Work Together
Scientists recently discovered different strains of deadly flesh-eating bacteria working together to spread infection and they now have a better understanding of the role of the toxins they produce. The discovery could change how the illness and other diseases are treated.
Utilizing Antibodies from Ebola Survivors
A collaborative team from The University of Texas Medical Branch at Galveston, Vanderbilt University, The Scripps Research Institute and Integral Molecular Inc. have learned that antibodies in the blood of people who have survived a strain of the Ebola virus can kill various types of Ebola.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!